D-0073-2027 Class II Ongoing
FDA drug recall D-0073-2027 was initiated by The Ritedose Corporation on Oct 15, 2026 and is designated Class II. Reason for recall: Failed Impurities/Degradation Specification The recall status is ongoing. Affected quantity: 3210 Cartons.
Recall details
- Product Type
- Drugs
- Report Date
- Nov 4, 2026
- Initiation Date
- Oct 15, 2026
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3210 Cartons
Product description
Formoterol Fumarate Inhalation Solution, 20mcg/2mL, packaged in cartons of 30 individually wrapped vials (NDC 76204-030-01) and 60 individually wrapped vials (NDC 76204-030-02), Rx only, Manufactured for and by: Ritedose Pharmaceuticals, LLC, Columbia, SC
Reason for recall
Failed Impurities/Degradation Specification
Distribution pattern
Nationwide within the U.S
Code information
Lot: 25BL0, Expires: 02/28/2027
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0073-2027
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026